• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

The $72 Million Talc Verdict Against J&J May Not Set a Precedent

By
Reuters
Reuters
Down Arrow Button Icon
By
Reuters
Reuters
Down Arrow Button Icon
February 26, 2016, 5:08 AM ET
LS010183
Photograph by Nancy R. Cohen — Getty Images

The $72 million verdict this week against Johnson & Johnson in a U.S. case alleging links between talc-based powder and ovarian cancer has prompted global headlines, social media buzz and calls to lawyers from would-be plaintiffs.

But the attention-grabbing judgment is no guarantee future plaintiffs will be able to convince juries the company’s products caused their illnesses.

About 1,200 similar cases are pending, primarily in Missouri and New Jersey state courts, but the facts are different in every one.

And even in cases with similar evidence and expert testimony, juries in mass personal-injury litigation can come to different conclusions.

While the survivors of Jacqueline Fox were awarded $72 million by a St. Louis jury Monday, jurors in a federal court action in South Dakota—the only other talc case to go to trial—found in 2013 that J&J (JNJ) had been negligent but declined to award damages to plaintiff Deane Berg.

Like Fox, Berg alleged her ovarian cancer was caused by her decades-long use of J&J’s talc-powder products for feminine hygiene, and jurors in both cases heard testimony about studies linking talc to cancer risks.

But, unlike Fox, who passed away several months before the trial began, Berg was in remission at the time of the trial, according to court documents.

In addition to factual differences among cases, venue can affect outcomes. Some state courts are considered more plaintiff-friendly than federal courts, which have stricter rules for the admission of evidence and expert testimony, said lawyers involved in the litigation.

One juror in the Missouri case, Jerome Kendrick, said in an interview with Reuters that he and other jurors were especially swayed by testimony from plaintiffs’ medical experts and documents showing J&J employees discussing talc powder’s possible cancer risk.

“The problem I had is that, according to inter office documents, J&J was aware of the potential concerns,” Kendrick said. “And it really looked like instead of trying to investigate, they started talking about how to combat what would eventually be a court case.”

J&J has said that “decades of sound science” prove that talc is safe. The company on Tuesday issued a statement expressing sympathy for Fox’s family but disagreeing with the verdict. It also said it is exploring its post-trial options.

Under the Radar

Talc litigation got its start in 2009, when Berg filed her lawsuit. The Fox lawsuit was selected by plaintiffs’ lawyers as the first to go to trial in Missouri, to serve as an early bellwether of how similar cases in that venue might fare.

The litigation flew largely under the public’s radar until jurors returned the award for the family of Fox, who died in October at 62. The plaintiffs said Fox used J&J Baby Powder and Shower to Shower Powder for feminine hygiene daily for 35 years before she was diagnosed three years ago with ovarian cancer.

It has resonated with the public far more than the Berg case, which “didn’t get headlines because they didn’t award any damages,” said R. Allen Smith, a Missouri-based lawyer who represented both the Fox family and Berg.

More cases may be filed soon, and lawyers at several plaintiffs’ firms who worked on the Fox case said they are investigating thousands of additional claims.

Still, the talc cases represent a relatively small portion of the tens of thousands of lawsuits J&J is facing over its many products. For instance, it is the target of more than 44,000 cases from women who say they were harmed by pelvic mesh devices made by its Ethicon unit, and more than 8,000 against its DePuy subsidiary regarding Pinnacle metal-on-metal hip systems.

The next J&J talc trial is set for April in St. Louis, and additional trial dates have been set for later this year.

To be successful, plaintiffs must make both a general link between talc and ovarian cancer and show that J&J’s products—as opposed to something else—are to blame for their cancer.

In spite of the increased interest in the litigation following the Fox verdict, attorney Danielle Mason of Beasley Allen, who was part of the team representing the Fox family at trial, said she expected J&J to fight hard to defend itself in upcoming trials. “We’re in this for the long haul,” she said.

About the Author
By Reuters
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Simple App Review (2026): Expert Tested and Reviewed
Healthmeal delivery
Simple App Review (2026): Expert Tested and Reviewed
By Emily PharesApril 30, 2026
22 hours ago
Premium card perks are ‘designed to create a win-win-win for everyone’ but customers are paying with heavy annual fees and data
Personal FinancePersonal Finance Evergreen
Premium card perks are ‘designed to create a win-win-win for everyone’ but customers are paying with heavy annual fees and data
By Catherina GioinoApril 30, 2026
23 hours ago
hoskins
Commentaryoffices
Gensler Co-Chair: Hot-desking was supposed to save money. It may be costing you your culture
By Diane HoskinsApril 30, 2026
1 day ago
raw milk
Politicsmilk
Risk of paralysis, bacteria, even death is no match for Americans’ thirst for raw milk
By Laura Ungar, Jonel Aleccia and The Associated PressApril 29, 2026
2 days ago
The Best Protein Shakes of 2026: Tasted and Approved by Nutrition Experts
HealthDietary Supplements
The Best Protein Shakes of 2026: Tasted and Approved by Nutrition Experts
By Christina SnyderApril 29, 2026
2 days ago
aging
HealthLongevity
We’re the CEOs of Peloton and the Hospital for Special Surgery. Living longer isn’t enough, we need to live better, too
By Bryan T. Kelly and Peter SternApril 29, 2026
2 days ago

Most Popular

China dominates the world's lithium supply. The U.S. just found 328 years' worth in its own backyard
North America
China dominates the world's lithium supply. The U.S. just found 328 years' worth in its own backyard
By Jake AngeloApril 30, 2026
21 hours ago
Accenture's Julie Sweet blew up 50 years of company history. She says the hardest part is still ahead
Conferences
Accenture's Julie Sweet blew up 50 years of company history. She says the hardest part is still ahead
By Nick LichtenbergApril 29, 2026
2 days ago
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regrets
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regrets
By Preston ForeApril 27, 2026
4 days ago
America shot its arsenal empty in 2 wars. Now it needs Beijing's permission to reload
Commentary
America shot its arsenal empty in 2 wars. Now it needs Beijing's permission to reload
By Steve H. Hanke and Jeffrey WengApril 30, 2026
22 hours ago
Exclusive: America's largest Black-owned bank launches podcast with mission to unlock hidden shame holding back generational wealth
Banking
Exclusive: America's largest Black-owned bank launches podcast with mission to unlock hidden shame holding back generational wealth
By Nick LichtenbergApril 29, 2026
2 days ago
Google Cloud revenue is now 18% of Alphabet's business. Is this the beginning of the end of Google's search identity?
Big Tech
Google Cloud revenue is now 18% of Alphabet's business. Is this the beginning of the end of Google's search identity?
By Alexei OreskovicApril 29, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.